Nuveen’s Avita Medical RCEL Stock Holding History

Nuveen’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$157K	Buy	42,389 +427	+1%	+$1.79K	﹤0.01%	3136
2025 Q4	$145K	Hold	41,962	–	–	﹤0.01%	3188
2025 Q3	$214K	Sell	41,962 -17,354	-29%	-$90.5K	﹤0.01%	3141
2025 Q2	$314K	Sell	59,316 -12,422	-17%	-$90.4K	﹤0.01%	3033
2025 Q1	$584K	Hold	71,738	–	–	﹤0.01%	2853
2024 Q4	$918K	Hold	71,738	–	–	﹤0.01%	2748
2024 Q3	$769K	Hold	71,738	–	–	﹤0.01%	2861
2024 Q2	$568K	Hold	71,738	–	–	﹤0.01%	2944
2024 Q1	$1.15M	Hold	71,738	–	–	﹤0.01%	2641
2023 Q4	$984K	Hold	71,738	–	–	﹤0.01%	2739
2023 Q3	$1.05M	Sell	71,738 -13,260	-16%	-$224K	﹤0.01%	2559
2023 Q2	$1.45M	Buy	+84,998	New	+$1.25M	﹤0.01%	2492
2022 Q2	–	Sell	-73,768	Closed	-$571K	–	3446
2022 Q1	$571K	Buy	73,768 +540	+0.7%	+$4.98K	﹤0.01%	2977
2021 Q4	$862K	Sell	73,228 -4,585	-6%	-$69.9K	﹤0.01%	2903
2021 Q3	$1.45M	Sell	77,813 -4,354	-5%	-$82.2K	﹤0.01%	2819
2021 Q2	$1.69M	Buy	+82,167	New	+$1.62M	﹤0.01%	2787

Other funds holding RCEL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nuveen's RCEL Position: Q1 2026 in Review

Nuveen increased its Avita Medical (RCEL) stake by 1% in Q1 2026, buying an estimated $1.79K and bringing the position to 42,389 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #3136.

Nuveen first reported a position in RCEL in Q2 2021 and has held it in 16 quarters since. The position peaked at $1.69M in Q2 2021. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

Nuveen held 42,389 shares of Avita Medical worth $157K as of Q1 2026.
Nuveen bought 427 Avita Medical shares in Q1 2026, an estimated $1.79K.
Avita Medical made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #3136 holding.
Nuveen first reported a position in Avita Medical in Q2 2021 and has held it in 16 quarters since.
Nuveen's Avita Medical position peaked at $1.69M in Q2 2021.
79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.